Cellular Injury — Reversible and Irreversible

Molecular and Biochemical Mechanisms

• ATP Depletion and Energy Failure: Severe reduction in cellular ATP production (via mitochondrial oxidative phosphorylation impairment) represents the critical turning point between reversible and irreversible injury. ATP depletion causes:
• Failure of Na⁺/K⁺-ATPase pump function, leading to sodium influx, cell swelling, and loss of cellular ion homeostasis
• Accumulation of intracellular Ca²⁺ due to impaired Ca²⁺-ATPase (SERCA pump) activity and increased membrane permeability
• Loss of protein synthesis capacity
• Inability to maintain cytoskeletal architecture
• In reversible injury, brief ATP depletion allows recovery; in irreversible injury, prolonged ATP loss triggers irreversible cascades

• Calcium-Mediated Injury Cascade: Intracellular calcium accumulation (normally maintained <100 nM in cytoplasm via sequestration in endoplasmic reticulum and mitochondria) is the most important mediator of irreversibility:
• Activation of calpains (Ca²⁺-dependent proteases) causing widespread cytoskeletal protein degradation (spectrin, actin, myosin)
• Activation of phospholipases (particularly phospholipase A₂) leading to membrane phospholipid breakdown and membrane blebbing
• Activation of endonucleases (CAD/DFF45) and increased nuclease activity causing DNA fragmentation
• Activation of protein kinase C and other signaling cascades
• Mitochondrial calcium overload triggering mitochondrial permeability transition and release of cytochrome c

• Oxidative Stress and Reactive Oxygen Species (ROS): Injurious stimuli (ischemia-reperfusion, xenobiotics, radiation) generate excessive ROS (superoxide anion, hydrogen peroxide, hydroxyl radical):
• ROS cause lipid peroxidation of polyunsaturated fatty acids in cell membranes, generating toxic secondary metabolites
• Protein oxidation and cross-linking, inactivating critical enzymes
• DNA damage via strand breaks and base modifications
• Depletion of antioxidant defenses: reduced glutathione (GSH), catalase, superoxide dismutase (SOD), and glutathione peroxidase
• Mitochondrial ROS production amplifies injury in irreversible stages

• Mitochondrial Dysfunction: The "point of no return" in cellular injury:
• Outer mitochondrial membrane permeabilization (MOMP) via Bcl-2 family dysregulation (pro-apoptotic Bax/Bak activation, anti-apoptotic Bcl-2/Bcl-xL loss)
• Opening of mitochondrial permeability transition pore (mPTP) caused by excessive Ca²⁺, oxidative stress, and phosphate accumulation
• mPTP opening uncouples oxidative phosphorylation, dissipates proton gradient, and causes rapid ATP collapse
• Release of cytochrome c and AIF (apoptosis-inducing factor) into cytoplasm
• In reversible injury, brief opening is tolerated; prolonged opening is irreversible

Morphological Changes

Reversible Injury Morphology

• Cellular swelling (hydropic change): Due to Na⁺/K⁺-ATPase failure and osmotic water influx; cell volume increases 20-30% with pale, rarefied cytoplasm
• Mitochondrial swelling: Reversible expansion of mitochondrial matrix
• Endoplasmic reticulum (ER) dilation: Due to calcium dysregulation and impaired protein synthesis
• Nuclear changes (reversible): Slight chromatin clumping, preserved membrane integrity, normal nucleolus
• Membrane blebbing: Early, focal blebs that may retract
• Preservation of plasma membrane integrity: Lactate dehydrogenase (LDH) remains intracellular
• Ultrastructurally: Preserved cristae density, intact outer membrane, minimal matrix electron density changes

Irreversible Injury Morphology

• Severe cell swelling with cell membrane rupture: Loss of cellular boundaries, entry of extracellular fluid; nuclear and organellar swelling continues
• Hyperchromatic, condensed nucleus (pyknosis): Dense, shrunken nucleus; eventually fragmented (karyorrhexis)
• Loss of membrane integrity: Allows entry of impermeant dyes (propidium iodide, trypan blue), leak of intracellular enzymes
• Mitochondrial injury: Flocculent densities, cristae loss, matrix rarefaction, calcification
• Myelin figures: Whorled phospholipid inclusions from membrane breakdown
• Preservation or condensation of ribosomes until late stages
• Nuclear fragmentation (karyorrhexis): Breakdown into multiple membrane-bound fragments
• Ultrastructurally: Complete cristae dissolution, outer membrane rupture, dense amorphous matrix material

Ischemic Injury (Most Common)

• Hypoxemia/Hypoxia: Severe reduction in oxygen availability—most critical factor as mitochondria depend on O₂ for ATP synthesis
• Systemic hypoxemia (respiratory failure, severe anemia, carbon monoxide poisoning, altitude)
• Regional ischemia (thrombosis, atherosclerotic occlusion, vasospasm, shock, prolonged hypotension)
• Ischemia-reperfusion injury: paradoxical worsening upon restoration of blood flow due to ROS generation and calcium overload
• Critical threshold: Most tissues tolerate 4-10 minutes complete ischemia; neurons tolerate only 4-6 minutes before irreversible damage occurs

Chemical/Toxic Injury

• Drugs and xenobiotics: Acetaminophen (glutathione depletion), chemotherapy agents (doxorubicin), alcohols
• Heavy metals: Lead, mercury, arsenic (impair mitochondrial function, generate ROS)
• Cyanide: Blocks cytochrome c oxidase, preventing ATP synthesis despite oxygen availability
• Excitotoxins: Glutamate, aspartate (excessive calcium influx in CNS)

Hyperthermia and Hypothermia

• Heat injury: Direct protein denaturation, increased membrane fluidity, ROS generation; neurons most vulnerable
• Cold injury: Crystallization of extracellular fluid, membrane phase transition, impaired mitochondrial function

Mechanical Trauma

• Crush injury: Direct cellular disruption, compartment syndrome leading to ischemia
• Shear stress: Vascular injury, platelet aggregation, thrombosis

Radiation

• Ionizing radiation: Direct DNA strand breaks, ROS generation
• Ultraviolet (UV) radiation: Pyrimidine dimer formation, ROS

Infectious Agents and Inflammation

• Bacterial/viral toxins: Direct membrane injury, mitochondrial toxins (Shiga toxin, diphtheria toxin)
• Cytokine-mediated injury: TNF-α, Fas ligand (apoptosis induction)
• Complement activation: Membrane attack complex formation

Immunologic Injury

• Autoimmune reactions: Antibody and complement-mediated cellular destruction
• Transplant rejection: Alloimmune attack on donor cells

Metabolic Derangements

• Hypoglycemia: Impaired substrate availability for ATP synthesis
• Electrolyte abnormalities: Severe hyponatremia, hyperkalemia
• Uremia: Accumulation of toxic metabolites

Genetic/Congenital Factors

• Mitochondrial cytopathies: Inherited mutations in mtDNA or nuclear genes encoding mitochondrial proteins
• Glycogen storage diseases: Impaired substrate metabolism
• Ion channelopathies: Altered cellular ion homeostasis

General Principles of Presentation

1. 1.The tissue/organ system affected (varies in sensitivity to specific injuries)
2. 2.Whether injury is reversible (functional impairment with potential recovery) or irreversible (leading to necrosis/apoptosis and cell death)
3. 3.The acuity and extent of injury
4. 4.The regenerative capacity of the affected tissue

Tissue-Specific Presentations

Myocardial Injury (Acute Coronary Syndrome/Myocardial Infarction)

• Cardinal symptoms: Acute chest pain (pressure, heaviness, radiation to arm/jaw), dyspnea, diaphoresis, nausea
• Reversible phase (minutes to hours): Chest discomfort with preserved cardiac function on urgent echocardiography if reperfused early; troponin elevation begins at 2-4 hours, peaks 24-48 hours
• Irreversible phase (>4-6 hours in absence of reperfusion): Progressive systolic dysfunction, cardiogenic shock, arrhythmias, cardiogenic pulmonary edema
• Physical exam: Tachycardia, hypotension (inferior MI), pulmonary rales, S3 gallop, new murmur (papillary muscle rupture, VSD)
• ECG findings: ST elevation or depression, T-wave inversions, pathological Q waves (irreversible transmural necrosis)
• Imaging (echocardiography): Regional wall motion abnormality, wall thinning with scar formation (irreversible), left ventricular thrombus

Cerebral Ischemia/Stroke

• Cardinal symptoms: Acute focal neurological deficits (weakness, aphasia, visual loss, ataxia)
• Reversible phase: Transient ischemic attack (TIA) with complete resolution; diffusion-weighted MRI (DWI) may be negative or show reversible ADC (apparent diffusion coefficient) changes
• Irreversible phase (>4.5 hours in most tissues, <6 hours in select cases with thrombectomy candidates): Permanent neurological deficit; infarction visible on follow-up CT/MRI with restricted diffusion
• Physical exam: Focal neurological signs (hemiparesis, hemisensory loss, cranial nerve deficits, aphasia, neglect)
• Neuroimaging: DWI hyperintensity (restricted water diffusion in infarcting tissue), vasogenic edema on FLAIR, hypodensity on CT (late sign)

Hepatocellular Injury (Drug-Induced/Viral Hepatitis)

• Reversible injury: Elevated transaminases (AST, ALT), mild jaundice if cholestasis present, hepatomegaly on palpation
• Cardinal symptoms: Malaise, abdominal discomfort, jaundice
• Irreversible injury (acute liver failure): Coagulopathy (elevated PT/INR), encephalopathy, severe hyperbilirubinemia, asterixis, altered mental status, profound acidosis
• Lab correlates:
• Reversible: ALT/AST elevation (often >1000 IU/L in acute viral hepatitis), normal or mildly elevated alkaline phosphatase
• Irreversible: Markedly prolonged PT/INR, hypoglycemia, lactic acidosis, elevated ammonia, creatinine elevation (hepatorenal syndrome)
• Imaging: Hepatomegaly, normal or mildly decreased echogenicity on ultrasound; advanced imaging shows decreased hepatic attenuation

Acute Kidney Injury (Ischemic vs. Nephrotoxic)

• Reversible phase (acute tubular necrosis—ATN): Oliguria or anuria, elevated serum creatinine (rises 1-2 mg/dL/day), elevated BUN, hyperkalemia, metabolic acidosis
• Cardinal symptoms: Reduced urine output, edema, dyspnea (if pulmonary edema)
• Physical exam: Hypertension, peripheral/pulmonary edema, signs of underlying cause
• Lab findings:
• Urinalysis: Muddy brown casts (pathognomonic for ATN), epithelial cell casts, proteinuria
• Serum: ↑ creatinine, ↑ potassium, ↑ phosphate, ↓ calcium, metabolic acidosis
• FENa >2% (fractional excretion of sodium, indicating intrinsic renal damage)
• Reversibility: Most ATN is reversible over days to weeks with supportive care; irreversible if severe with cortical necrosis

Thermal Injury (Burns, Hypothermia)

• Heat injury: Progressive tissue necrosis with surrounding inflammation; reversible thermal injury shows erythema; irreversible injury causes coagulation necrosis (eschar)
• Hypothermia: Initial reversible cold injury (vasoconstriction, bradycardia, reduced metabolism); irreversible injury causes "ice crystal formation," frostbite with tissue gangrene
• Physical findings: Erythema, edema (reversible); blackened tissue, fixed purpura (irreversible); "frozen" appearance in hypothermia

Toxic Exposure (Acetaminophen, Heavy Metals)

• Reversible phase: Mild abdominal pain, elevated transaminases
• Irreversible phase: Fulminant hepatic failure, renal failure, death within 48-72 hours if untreated
• Lab findings: Dramatically elevated transaminases (>10,000 IU/L), prolonged PT/INR, hypoglycemia, lactic acidosis

Histopathological Findings

Light Microscopy - Reversible Injury

• Cellular swelling (hydropic change): Cells appear pale, swollen, with slight nuclear enlargement; cytoplasm appears rarefied with reduced basophilia
• Mitochondrial swelling: Difficult to visualize on light microscopy; implied by cytoplasmic pallor
• ER dilation: Contributes to cytoplasmic pallor; ribosomes appear "diluted"
• Preservation of nuclear membrane and chromatin pattern: Nuclei remain round/oval with evenly distributed chromatin
• Absence of inflammatory infiltrate: Distinguishes from acute inflammation

Light Microscopy - Irreversible Injury (Cell Necrosis)

• Acute necrosis: Characterized by the classic triad:

1. 1.Nuclear changes (karyolysis, pyknosis, karyorrhexis):

• Pyknosis: Shrunken, hyperchromatic nucleus with condensed heterochromatin ("ink-drop" appearance)
• Karyorrhexis: Fragmentation of pyknotic nucleus into membrane-bound fragments
• Karyolysis: Complete dissolution of nucleus; naked cell appears

1. 1.Cytoplasmic changes:

• Eosinophilia (pink on H&E): Due to increased protein concentration and loss of basophilic RNA (ribosomes degrade)
• Loss of cytoplasmic detail: Organelles become indistinct
• "Ghost cells": Shadowy outlines of necrotic cells with loss of internal architecture

1. 1.Membrane integrity loss: Allows inflammatory cell infiltration around necrotic cells (→ coagulation necrosis pattern with zonal distribution)

• Coagulation necrosis (ischemic necrosis): Preserved cellular outline with loss of internal detail; most common pattern in cardiac infarcts, cerebral infarcts, renal infarcts; reflects maintenance of fibrin scaffold after cell death
• **Coll

Immediate stabilisation — restore oxygen and substrate delivery

• Airway, breathing, circulation: because irreversible injury is driven by ATP collapse, the first intervention is always restoration of perfusion and oxygenation — supplemental O₂ only if hypoxemic (routine oxygen in normoxemic ischemia is discouraged by ACC/AHA), isotonic crystalloid or vasopressors for shock, and correction of hypoglycemia.
• Reverse the specific poison of oxidative phosphorylation: cyanide — hydroxocobalamin (with or without sodium thiosulfate); carbon monoxide — high-flow/hyperbaric oxygen; methemoglobinemia — methylene blue. These act upstream of the mitochondrial "point of no return".

First-line, organ-specific reperfusion or antidote

• Myocardial ischemia: per ACC/AHA acute coronary syndrome guidance, primary PCI is preferred reperfusion for STEMI, with fibrinolytics (fibrin-specific agent, e.g. tenecteplase) when timely PCI is unavailable; adjuncts are antiplatelets (aspirin plus a P2Y12 inhibitor such as ticagrelor) and anticoagulation.
• Cerebral ischemia: per AHA/ASA acute ischemic stroke guidelines, IV thrombolysis (alteplase or tenecteplase) within the approved window plus mechanical thrombectomy for large-vessel occlusion; salvage of the ischemic penumbra is the entire therapeutic rationale.
• Acetaminophen hepatotoxicity: N-acetylcysteine, a glutathione precursor that replenishes the antioxidant reserve depleted by NAPQI — give on the basis of the Rumack-Matthew nomogram or risk, and never delay it awaiting levels (AASLD acute liver failure guidance).
• Ischemic acute tubular necrosis: KDIGO recommends volume repletion, hemodynamic optimisation, and withdrawal of nephrotoxins; there is no drug that reverses established tubular necrosis.

Escalation and definitive management

• Organ support: renal replacement therapy for refractory hyperkalemia, acidosis, or volume overload (KDIGO); mechanical circulatory support for cardiogenic shock; transplantation for irreversible hepatic necrosis (King's College criteria inform listing).
• Surgical: fasciotomy for compartment syndrome, debridement/revascularisation for gangrene, decompressive craniectomy for malignant cerebral edema.

Contraindicated / low-value

• Low-dose "renal" dopamine and loop diuretics to convert oliguric AKI: KDIGO recommends against — they alter urine output, not survival.
• Thrombolysis with active hemorrhage or recent intracranial bleed, and corticosteroids or routine antioxidant supplements for established necrosis, which have no proven benefit.

Complications of the injury itself

• Ischemia–reperfusion injury: restoring flow floods reoxygenated tissue with ROS, calcium, activated neutrophils, and complement, paradoxically extending necrosis. Signalled by contraction band necrosis in myocardium and by clinical deterioration despite successful reperfusion.
• Hemorrhagic (red) infarction: necrotic capillaries rupture when blood re-enters loose or dual-supply tissue (brain, lung, bowel). Hemorrhagic transformation of a cerebral infarct after thrombolysis is a neurologic emergency — sudden headache, vomiting, or drop in GCS mandates immediate non-contrast CT.
• Hyperkalemia and metabolic acidosis: lysed cells dump intracellular K⁺ and generate lactate. Peaked T waves with QRS widening is an emergency requiring IV calcium for membrane stabilisation.
• Rhabdomyolysis with pigment nephropathy: myoglobin from necrotic myocytes obstructs and directly injures tubules — markedly elevated CK, urine dipstick positive for blood with few RBCs on microscopy.
• Compartment syndrome: swelling within a fixed fascial space creates a self-perpetuating ischemic loop; surgical emergency heralded by pain out of proportion and pain on passive stretch, not by loss of pulses.
• Systemic inflammatory response / multiorgan failure: necrosis releases DAMPs that ignite innate immunity.
• Late structural sequelae: fibrous scar and loss of contractile mass (ventricular aneurysm, cirrhosis, chronic kidney disease); dystrophic calcification in necrotic tissue despite normal serum calcium; free-wall or papillary muscle rupture in the softened days-old infarct — a cardiac emergency presenting as tamponade or new murmur with flash pulmonary edema.

Complications of treatment

• Bleeding, including intracranial hemorrhage, from fibrinolytics and antithrombotics.
• Contrast-associated AKI and cholesterol embolisation after angiography — rising creatinine, livedo reticularis, eosinophilia.
• No-reflow phenomenon after PCI: microvascular plugging leaves tissue unperfused despite an open epicardial artery.
• N-acetylcysteine anaphylactoid reactions (histaminergic, infusion-rate related) — usually managed by slowing the infusion, not by abandoning the antidote.
• Cerebral edema in acute liver failure — an emergency signalled by rising ICP and worsening encephalopathy.

• Cellular swelling is the earliest and most universal reversible change, and its mechanism is failure of the Na⁺/K⁺-ATPase from ATP depletion. The earliest ultrastructural clue examiners like is ribosome detachment from the rough ER with polysome disaggregation — both fully reversible.
• **The two morphologic markers of irreversibility are severe mitochondrial injury (vacuolisation with amorphous flocculent densities) and plasma membrane defects.** Myelin figures and enzyme leak (troponin, LDH, transaminases) mean the membrane is already breached.
• Cytosolic calcium is the final common mediator — it activates calpains, phospholipase A₂, endonucleases, and opens the mPTP. If a stem asks which single ion accumulation commits the cell to death, it is Ca²⁺, not Na⁺.
• Ischemia injures faster and more severely than pure hypoxia because it removes glycolytic substrate and lets acidic metabolites accumulate; in hypoxia alone, anaerobic glycolysis can be sustained.
• Coagulative necrosis with preserved cell outlines follows ischemia in every organ except the brain, where liquefactive necrosis predominates — the classic distractor.
• Reperfusion buzzwords: contraction band necrosis and ROS-mediated extension of infarct size. Reperfusion is still the correct next step — per ACC/AHA and AHA/ASA, the benefit of restoring flow outweighs reperfusion injury within the treatment window.
• Apoptosis is ATP-dependent, membrane-intact, and non-inflammatory (cell shrinkage, eosinophilic cytoplasm, pyknotic nucleus, apoptotic bodies); necrosis is ATP-depleted, membrane-ruptured, and inflammatory. Do not attribute a neutrophilic infiltrate to apoptosis.
• Best next step traps: in suspected acetaminophen toxicity, give N-acetylcysteine before levels return; in suspected hyperkalemia with ECG changes, give IV calcium before insulin/dextrose; in oliguric AKI, optimise perfusion — KDIGO recommends against low-dose dopamine or diuretics to "restart" the kidney.